Injective Coin or
INJ has been making substantial promises and innovations in the cryptocurrency market, as showcased by recent occurrences. It dropped by 3.9% due to a flush in derivatives and, interestingly, launched a native Ethereum Virtual Machine or EVM, promising faster and cheaper DeFi operations. Korean University's Blockchain Institute has partnered up with Injective as a validator in its global ecosystem, indicating a growing interest in its model.
Additionally, an application to establish a Staked Injective ETF has been submitted by Canary Capital, demonstrating external confidence in INJ. Possibly, a significant shift was approved by the Injective Community, implementing a supply squeeze in the tokenomics.
Awarding more bullish impressions, major financial institution Pineapple Financial initiated a migration of its $10B mortgage portfolio on-chain via Injective. Simultaneously, the Injective Community's approval for a proposal to slash the INJ Token's supply has further stirred interest.
In line with this, Canary Capital filed for an INJ ETF with staking rewards, marking it the first of its kind. A $8.9M buy from Pineapple brought significant capital into Injective's market. The community has revealed significant developments, such as unveiling a no-Code platform for Web3 builders. Notwithstanding, Binance temporarily suspended INJ deposits and withdrawals for a network upgrade.
Injective has shown ambitious movements in initiating the first on-chain digital treasury, injecting optimism the largely stable cryptocurrency market. Overall, numerous developments indicate a bullish sentiment towards INJ Coin's future performance, along with a distinct level of innovation and informative abilities, contributing to its apparent potential.
Injective Coin News Analytics from Thu, 03 Mar 2022 03:34:04 GMT to Mon, 02 Feb 2026 16:20:48 GMT -
Rating 7
- Innovation 7
- Information 8
- Rumor 4
